Abstract
Gliomas are known for their poor prognosis and tendency to develop resistance to chemotherapies currently available in the clinic. There is evidence of the ability of polyunsaturated fatty acids (PUFAs) of the n-3 family, eicosapentaenoic acid (20:5 n-3) (EPA) and docosahexaenoic acid (22:6 n-3) (DHA), to interfere with resistance to chemotherapy in various tumours. PUFAs can influence as…